Skip to main
MOLN
MOLN logo

MOLN P/E Ratio

P/E Ratio as of Jun 13, 2025: -1.99

Average-1.98
Median-1.99
Minimum-2.11
Maximum-1.85
-1.99
Past Month+0.13 (6.13%)
The P/E ratio for MOLN is -1.99 as of Jun 13, 2025. This represents a decrease of -23.75% compared to its 12-month average P/E ratio of -2.61. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.

Molecular Partners AG P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)

Molecular Partners AG’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Molecular Partners AG to industry peers.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

MOLN P/E Ratio Historic Data

DateStock priceP/E ratio
Jun 2, 2025$3.79-1.97
May 1, 2025$3.7475-2.07
Apr 1, 2025$3.84-2.12
Mar 3, 2025$5.03-2.34
Feb 3, 2025$5.05-2.35
Jan 2, 2025$4.87-2.27

MOLN End of Year P/E Ratio

DateP/E ratioChange
2025-1.99-9.95%
2024-2.21+1.84%
2023-2.17-231.52%
20221.65-119.46%
2021-8.48

FAQs About Molecular Partners AG (MOLN) P/E ratio

The latest P/E ratio of MOLN is -1.99, as of Jun 13, 2025. This is calculated based on its current stock price and earnings per share (EPS).

Molecular Partners AG’s last 12-month average P/E ratio is -2.61, compared to its current P/E ratio of -1.99. This reflects a decrease of -23.75%.

Molecular Partners AG’s current P/E ratio of -1.99 is lower than its last 12-month average P/E of -2.61. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.

Molecular Partners AG’s average P/E ratio over the last 3 years is -1.57. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.

Molecular Partners AG’s average P/E ratio over the last 5 years is -2.14. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.

Molecular Partners AG (MOLN)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.